10902 N. McKinley Drive
12 articles with M2Gen
M2GEN-supported research network ORIEN® begins COVID-19 study in cancer patients funded through the ORIEN Foundation
The Oncology Research Information Exchange Network (ORIEN), an alliance of 18 of the top national cancer centers, announced today the initiation of a COVID-19 study in cancer patients funded through the ORIEN Foundation. ORIEN members have the unique potential to contribute significantly to understanding not only the short-term effects
M2GEN and Discovery Life Sciences Enter into Agreement to Leverage M2GEN's New Oncology-Focused Bioinformatics Support Services
M2GEN announced today that it has entered into an agreement with Discovery Life Sciences, a global leader in biospecimen solutions, genomic, cell, and immunohistochemistry (IHC) services, to provide M2GEN's recently launched oncology-focused bioinformatics support services.
M2GEN, an oncology-focused health informatics solutions company with the mission to help patients access the best treatment options by leveraging their clinical and molecular data to accelerate the discovery, development and delivery of tailored and more personalized therapies, announced today the appointment of Chris Tunnell as Vice Pres
8/16/2019Biopharma companies strengthen their executive ranks and boards with new additions.
Bastian succeeds M2Gen Executive Chair William S. Dalton, M.D., Ph.D., who has served as interim CEO since September 2018.
M2Gen announced today that Bristol-Myers Squibb has joined the Oncology Research Information Exchange Network Avatar Research Program.
AbbVie And M2Gen Announce New Collaboration For The Oncology Research Information Exchange Network (ORIEN) Avatar Research Program
M2Gen Announces That Merck & Co. Joins The Oncology Research Information Exchange Network (ORIEN) Avatar Research Program
Takeda And M2Gen Collaborate With ORIEN To Speed Clinical Development And Discovery Of Cancer Treatments Through Health Informatics
M2Gen Release: Leading Cancer Centers And Biopharmaceutical Companies Launch Unprecedented Alliance To Advance Development Of Precision Medicines For Cancer Patients